Copertina

Phototherapy for atopic dermatitis: Is the light still shining?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Adrian Tanew
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of the European Academy of Dermatology and Venereology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The long road to atopic disease modification in infants with atopic dermatitis
di: Thomas Hultsch
Pubblicazione: (2024)

French guidelines for the management of atopic dermatitis
di: Nina Sigg, et al.
Pubblicazione: (2025)

Psychological impact on flare patterns and severity of atopic dermatitis
di: Mia‐Louise Nielsen, et al.
Pubblicazione: (2024)

Langerhans cells: Central players in the pathophysiology of atopic dermatitis
di: Yi Pan, et al.
Pubblicazione: (2024)

An alternative interpretation of the diagnosis of atopic dermatitis in the Boy with an Orange
di: Nicolas Kluger
Pubblicazione: (2026)

Infectious risk with JAKi : What about atopic dermatitis?
di: Lea Hoisnard, et al.
Pubblicazione: (2025)

Impact of light dose and fluence rate on the efficacy and tolerability of topical 5‐ALA photodynamic therapy for actinic keratoses: A randomized, controlled, observer‐blinded intrapatient comparison study
di: Adrian Tanew, et al.
Pubblicazione: (2024)

T helper and IL ‐20 cytokine signatures distinguish atopic dermatitis from contact dermatitis subtypes
di: Axel De Greef, et al.
Pubblicazione: (2025)

Addressing existing gaps in the management of young adults with atopic dermatitis
di: Magdalena Trzeciak, et al.
Pubblicazione: (2024)

Leveraging artificial intelligence to pursue treatment personalization in atopic dermatitis
di: Bruno Duarte
Pubblicazione: (2024)

Dissecting the roles of oxidative stress gene expression in atopic dermatitis
di: Zhi‐Qing Zhan, et al.
Pubblicazione: (2024)

Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy
di: Christian Vestergaard, et al.
Pubblicazione: (2025)

Tattoos in patients with atopic dermatitis: What the dermatologist should know?
di: Nicolas Kluger
Pubblicazione: (2025)

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis
di: Tiago Torres, et al.
Pubblicazione: (2026)

Impact of prior biologic exposure on drug survival in atopic dermatitis
di: Xu Li, et al.
Pubblicazione: (2025)

Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab
di: Andrew Blauvelt, et al.
Pubblicazione: (2025)

Correspondence to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis’
di: Shiuan‐Chih Chen, et al.
Pubblicazione: (2025)

Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
di: Sheng Li, et al.
Pubblicazione: (2025)

Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitis
di: Melina Fonfara, et al.
Pubblicazione: (2024)

Drug survival of abrocitinib compared to dupilumab in adult patients with atopic dermatitis
di: Qingjie Hu, et al.
Pubblicazione: (2024)

Fears for tears? Targeted therapies for atopic dermatitis and ocular surface health
di: Carolyn Jack, et al.
Pubblicazione: (2024)

Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
di: Joséphine Dupuis, et al.
Pubblicazione: (2024)

New bricks in the wall regarding the link between obesity and atopic dermatitis
di: Teofila Seremet
Pubblicazione: (2024)

Dupilumab facial dermatitis in atopic dermatitis patients ameliorated by topical crisaborole: An open‐label case series study
di: Han‐Wen Lin, et al.
Pubblicazione: (2024)

Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis
di: Teppei Hagino, et al.
Pubblicazione: (2025)

Reply to comments by Tadulewicz and Muklewicz on socio‐economic outcomes of atopic dermatitis
di: Sigrun Alba Johannesdottir Schmidt, et al.
Pubblicazione: (2025)

Psychotherapeutic interventions improve disease severity and quality of life in atopic dermatitis
di: Genevieve Arany‐Lao‐Kan, et al.
Pubblicazione: (2025)

Understanding socioeconomic outcomes in Danish children with moderate‐to‐severe atopic dermatitis
di: Ilona Tadulewicz, et al.
Pubblicazione: (2025)

Sexual orientation and gender identity in clinical trials of atopic dermatitis and psoriasis
di: Michael J. Martinez, et al.
Pubblicazione: (2025)

Critical methodological enhancements for JAK inhibitor safety studies in atopic dermatitis
di: Zheying Huang, et al.
Pubblicazione: (2025)

Methotrexate for atopic dermatitis: The right dosing and best‐performance administration route
di: A. Nosbaum, et al.
Pubblicazione: (2025)

Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab
di: Hyungdon Kook, et al.
Pubblicazione: (2024)

The wide spectrum of disease burden in atopic dermatitis—Implications for more holistic approaches?
di: Alexander Salava
Pubblicazione: (2024)

Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis
di: Claire Fossati, et al.
Pubblicazione: (2024)

International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study
di: Anouk G. M. Caron, et al.
Pubblicazione: (2024)

Primary localized cutaneous amyloidosis associated with atopic dermatitis treated successfully with nemolizumab
di: Takeshi Fukumoto, et al.
Pubblicazione: (2024)

Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial
di: Shiuan‐Chih Chen, et al.
Pubblicazione: (2025)

Thromboembolic risk with JAK inhibitors in atopic dermatitis: Context, caution and clinical relevance
di: Joseph V. Caravaglio
Pubblicazione: (2025)

Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata
di: Eleonora De Luca, et al.
Pubblicazione: (2025)

Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
di: Christopher G. Bunick, et al.
Pubblicazione: (2025)